MyAverix Finance
TWO · Healthcare
Medigen Vaccine Biologics (6547)
Biotechnology
Medigen Vaccine Biologics (6547) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6547
Medigen Vaccine Biologics (6547) — FAQ
What is 6547's P/E ratio?
The price-to-earnings (P/E) ratio for Medigen Vaccine Biologics (6547) is 25.00 (data as of 2026-05-23).
Does Medigen Vaccine Biologics pay a dividend?
Dividend yield is not available in the current snapshot for Medigen Vaccine Biologics (6547). Check the MyAverix Finance app for the latest dividend data.
What sector is Medigen Vaccine Biologics in?
Medigen Vaccine Biologics (6547) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6547 listed on?
6547 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.